These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 20206137)

  • 21. Structure of a Signaling Cannabinoid Receptor 1-G Protein Complex.
    Krishna Kumar K; Shalev-Benami M; Robertson MJ; Hu H; Banister SD; Hollingsworth SA; Latorraca NR; Kato HE; Hilger D; Maeda S; Weis WI; Farrens DL; Dror RO; Malhotra SV; Kobilka BK; Skiniotis G
    Cell; 2019 Jan; 176(3):448-458.e12. PubMed ID: 30639101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GPR55 - a putative "type 3" cannabinoid receptor in inflammation.
    Yang H; Zhou J; Lehmann C
    J Basic Clin Physiol Pharmacol; 2016 May; 27(3):297-302. PubMed ID: 26669245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional selectivity at G-protein coupled receptors: Advancing cannabinoid receptors as drug targets.
    Mallipeddi S; Janero DR; Zvonok N; Makriyannis A
    Biochem Pharmacol; 2017 Mar; 128():1-11. PubMed ID: 27890725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ligand- and heterodimer-directed signaling of the CB(1) cannabinoid receptor.
    Hudson BD; Hébert TE; Kelly ME
    Mol Pharmacol; 2010 Jan; 77(1):1-9. PubMed ID: 19837905
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential G protein-coupled cannabinoid receptor signaling by anandamide directs blastocyst activation for implantation.
    Wang H; Matsumoto H; Guo Y; Paria BC; Roberts RL; Dey SK
    Proc Natl Acad Sci U S A; 2003 Dec; 100(25):14914-9. PubMed ID: 14645706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biochemical and pharmacological control of the multiplicity of coupling at G-protein-coupled receptors.
    Hermans E
    Pharmacol Ther; 2003 Jul; 99(1):25-44. PubMed ID: 12804697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cannabinoid signalling in the enteric nervous system.
    Galligan JJ
    Neurogastroenterol Motil; 2009 Sep; 21(9):899-902. PubMed ID: 19689654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Emerging Role of the Cannabinoid Receptor Family in Peripheral and Neuro-immune Interactions.
    Haugh O; Penman J; Irving AJ; Campbell VA
    Curr Drug Targets; 2016; 17(16):1834-1840. PubMed ID: 26758668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modelling and simulation of biased agonism dynamics at a G protein-coupled receptor.
    Bridge LJ; Mead J; Frattini E; Winfield I; Ladds G
    J Theor Biol; 2018 Apr; 442():44-65. PubMed ID: 29337260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Special issue editorial: Cannabinoid signalling in the brain: New vistas.
    Busquets-Garcia A; Melis M; Bellocchio L; Marsicano G
    Eur J Neurosci; 2022 Feb; 55(4):903-908. PubMed ID: 35118747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiplicity and regulation of G-protein couplings.
    Hermans E
    Bull Mem Acad R Med Belg; 2009; 164(5-6):255-62. PubMed ID: 20666155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CB(1) cannabinoid receptor-G protein association: a possible mechanism for differential signaling.
    Mukhopadhyay S; Shim JY; Assi AA; Norford D; Howlett AC
    Chem Phys Lipids; 2002 Dec; 121(1-2):91-109. PubMed ID: 12505694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cannabinoid receptors and the regulation of immune response.
    Berdyshev EV
    Chem Phys Lipids; 2000 Nov; 108(1-2):169-90. PubMed ID: 11106790
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The CB(1) cannabinoid receptor juxtamembrane C-terminal peptide confers activation to specific G proteins in brain.
    Mukhopadhyay S; McIntosh HH; Houston DB; Howlett AC
    Mol Pharmacol; 2000 Jan; 57(1):162-70. PubMed ID: 10617691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cannabinoids and the gut: new developments and emerging concepts.
    Izzo AA; Sharkey KA
    Pharmacol Ther; 2010 Apr; 126(1):21-38. PubMed ID: 20117132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inverse agonism at serotonin and cannabinoid receptors.
    Aloyo VJ; Berg KA; Clarke WP; Spampinato U; Harvey JA
    Prog Mol Biol Transl Sci; 2010; 91():1-40. PubMed ID: 20691957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GPR55 ligands promote receptor coupling to multiple signalling pathways.
    Henstridge CM; Balenga NA; Schröder R; Kargl JK; Platzer W; Martini L; Arthur S; Penman J; Whistler JL; Kostenis E; Waldhoer M; Irving AJ
    Br J Pharmacol; 2010 Jun; 160(3):604-14. PubMed ID: 20136841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cannabinoids and bone: friend or foe?
    Idris AI; Ralston SH
    Calcif Tissue Int; 2010 Oct; 87(4):285-97. PubMed ID: 20532878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A kinetic model of GPCRs: analysis of G protein activity, occupancy, coupling and receptor-state affinity constants.
    Stein RS; Ehlert FJ
    J Recept Signal Transduct Res; 2015; 35(4):269-83. PubMed ID: 25353707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional selectivity in cannabinoid signaling.
    Varga EV; Georgieva T; Tumati S; Alves I; Salamon Z; Tollin G; Yamamura HI; Roeske WR
    Curr Mol Pharmacol; 2008 Nov; 1(3):273-84. PubMed ID: 20021440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.